Explore more publications!
Healthcare Press Brazil
Got News to Share?

Press Releases

Men Balance Pro: How the "Triple-Action Formula" is Revolutionizing Men's Wellness Support (2026 Consumer Report)
Feb. 3, 2026

Men Balance Pro: How the "Triple-Action Formula" is Revolutionizing Men's Wellness Support (2026 Consumer Report)

Indeterminate GlobeNewswire, Inc.
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
Feb. 3, 2026

Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®

Indeterminate GlobeNewswire, Inc.
Global Pharmaceutical Filtration Market Projected to Achieve 11.1% CAGR Through 2030
Feb. 2, 2026

Global Pharmaceutical Filtration Market Projected to Achieve 11.1% CAGR Through 2030

Indeterminate GlobeNewswire, Inc.
Skincare Market Size to Reach USD 340.25 Billion by 2035, Driven by Clean Beauty and Wellness Trends
Feb. 2, 2026

Skincare Market Size to Reach USD 340.25 Billion by 2035, Driven by Clean Beauty and Wellness Trends

Indeterminate GlobeNewswire, Inc.
FEMSA assumes full ownership of OXXO Brazil
Feb. 2, 2026

FEMSA assumes full ownership of OXXO Brazil

Indeterminate GlobeNewswire, Inc.
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

Indeterminate GlobeNewswire, Inc.
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

Indeterminate GlobeNewswire, Inc.
Clinical Nail Care Products Market to Surpass USD 4.5 Billion by 2036 as Medical Management Replace Cosmetic Concealment
Jan. 22, 2026

Clinical Nail Care Products Market to Surpass USD 4.5 Billion by 2036 as Medical Management Replace Cosmetic Concealment

Neutral EIN Presswire
Medical Advocacy Services Market Is Booming Worldwide 2026-2033 | Patient Advocate Foundation, Health Advocate Inc
Jan. 22, 2026

Medical Advocacy Services Market Is Booming Worldwide 2026-2033 | Patient Advocate Foundation, Health Advocate Inc

Neutral EIN Presswire
Plant-Protein Sachets Market to Reach USD 1,516.1 Million by 2036 as Single-Serve Nutrition Drives Steady Growth
Jan. 30, 2026

Plant-Protein Sachets Market to Reach USD 1,516.1 Million by 2036 as Single-Serve Nutrition Drives Steady Growth

Neutral EIN Presswire
Medical Device Security Market Is Booming Worldwide 2026-2033 | Siemens Healthineers, GE Healthcare, Philips Healthcare
Jan. 21, 2026

Medical Device Security Market Is Booming Worldwide 2026-2033 | Siemens Healthineers, GE Healthcare, Philips Healthcare

Neutral EIN Presswire
Pharmaceutical Packaging Laminates Market Trends for 2026
Jan. 21, 2026

Pharmaceutical Packaging Laminates Market Trends for 2026

Indeterminate GlobeNewswire, Inc.
Born at Saudi Arabia’s FII, FC Mother Signs 5-Year FIFA World Cup Legacy Partnership And Sets 3 Global Health Records
Jan. 28, 2026

Born at Saudi Arabia’s FII, FC Mother Signs 5-Year FIFA World Cup Legacy Partnership And Sets 3 Global Health Records

Neutral EIN Presswire
Rayya Wellness Introduces Rayya Talks: First Edition Brings Together Leading Voices for an Evening on Intention Setting
Jan. 28, 2026

Rayya Wellness Introduces Rayya Talks: First Edition Brings Together Leading Voices for an Evening on Intention Setting

Neutral EIN Presswire
Clinical Trials Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036
Jan. 20, 2026

Clinical Trials Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036

Neutral EIN Presswire
Sulforaphane Market Shows Strong Growth Driven by Health Awareness and Plant-Based Trends
Jan. 28, 2026

Sulforaphane Market Shows Strong Growth Driven by Health Awareness and Plant-Based Trends

Neutral EIN Presswire
Global Low-Sodium Olive Brine Flavor Systems Market Set to Triple by 2036 Driven by Health-Conscious Consumer Demand
Jan. 28, 2026

Global Low-Sodium Olive Brine Flavor Systems Market Set to Triple by 2036 Driven by Health-Conscious Consumer Demand

Neutral EIN Presswire
89 Injured as Lightning Strikes Rally in Brazil
Jan. 27, 2026

89 Injured as Lightning Strikes Rally in Brazil

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Nuts Market Size to Reach US$ 84.5 Bn by 2033 Driven by Rising Health Awareness and Snack Demand
Jan. 26, 2026

Nuts Market Size to Reach US$ 84.5 Bn by 2033 Driven by Rising Health Awareness and Snack Demand

Neutral EIN Presswire
Lightning Injures Protesters at Bolsonaro Rally in Brazil
Jan. 27, 2026

Lightning Injures Protesters at Bolsonaro Rally in Brazil

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions